rs7834555 — BCO1

Intergenic GWAS tag SNP near the BCO1 pathway, associated with circulating beta-carotene and retinol levels independently of the functional BCO1 coding variants

See your personal result for BCO1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

BCO1 Region Variant — A Third Independent Influence on Beta-Carotene Status

The BCO1 gene (also known as BCMO1) encodes beta-carotene 15,15'-monooxygenase11 beta-carotene 15,15'-monooxygenase
The enzyme that cleaves dietary beta-carotene into two molecules of retinal, which is then reduced to retinol — the form of vitamin A used by the body, the central enzyme in the conversion of plant-based provitamin A into biologically active vitamin A. Most people are familiar with BCO1 through its two well-studied coding variants — rs7501331 (Ala379Val) and rs12934922 (Arg267Ser) — which directly reduce enzyme activity by up to 69% in compound carriers. The rs7834555 variant represents a third, independently acting influence on circulating beta-carotene and retinol levels, identified through genome-wide association analysis of circulating carotenoid concentrations.

The Mechanism

Unlike the coding BCO1 variants that alter the enzyme's amino acid sequence, rs7834555 is an intergenic variant22 intergenic variant
Located between protein-coding genes; does not directly change any protein but can influence gene regulation through effects on enhancers, transcription factor binding sites, or chromatin accessibility located on chromosome 8 at position 81,785,390 (GRCh38). Its mechanistic connection to carotenoid metabolism is not yet characterized at the molecular level. The variant likely acts as a GWAS tag SNP33 GWAS tag SNP
A marker in linkage disequilibrium with a functional variant nearby, which has not yet been pinpointed; the tag SNP's association reflects the true causal variant's effect, meaning it serves as a detectable signal for a nearby regulatory element that modulates expression or activity of a gene in the broader carotenoid absorption and conversion pathway.

The intestinal absorption and conversion of beta-carotene is a multi-step process involving several proteins beyond BCO1 itself: membrane transporters such as SR-B1 (SCARB1)44 SR-B1 (SCARB1)
Scavenger receptor class B type 1 — a lipid transport protein that facilitates uptake of carotenoids and other fat-soluble compounds into enterocytes and CD3655 CD36
A fatty acid translocase that also facilitates carotenoid uptake at the intestinal brush border, retinaldehyde reductases, and CRBP chaperone proteins. Genetic variation that influences any of these steps will independently affect circulating carotenoid and retinol levels.

The Evidence

The association of rs7834555 with circulating beta-carotene and retinol levels comes from genome-wide association study data. The broader framework for understanding how genetic variation near BCO1 modulates carotenoid metabolism was established by Ferrucci et al. 200966 Ferrucci et al. 2009
Ferrucci L et al. Common variation in the β-carotene 15,15′-monooxygenase 1 gene affects circulating levels of carotenoids. Am J Hum Genet, 2009, who performed the first GWAS of circulating carotenoids, identifying the BCMO1/BCO1 locus on chromosome 16 as the strongest genetic determinant of plasma beta-carotene levels.

Subsequent work by Lietz et al. 201277 Lietz et al. 2012
Lietz G et al. Single nucleotide polymorphisms upstream from the β-carotene 15,15′-monoxygenase gene influence provitamin A conversion efficiency in female volunteers. J Nutr, 2012 demonstrated that upstream regulatory SNPs near BCO1 (rs6420424, rs11645428, rs6564851) reduced BCMO1 catalytic activity by 48-59% independently of the coding variants, confirming that non-coding variation is a major contributor to the wide interindividual variability in beta-carotene conversion.

Hendrickson et al. 201288 Hendrickson et al. 2012
Hendrickson SJ et al. β-Carotene 15,15′-monooxygenase 1 SNPs in relation to plasma carotenoid and retinol concentrations in women of European descent. Am J Clin Nutr, 2012 showed that a genetic score using multiple BCO1-region SNPs predicted plasma beta-carotene concentrations with a 48% difference across extreme quintiles in 2,344 European women — underscoring that the full genetic picture of carotenoid metabolism requires considering multiple independent signals.

The evidence for rs7834555 specifically as an independent signal should be considered emerging until replicated in peer-reviewed publications with reported effect sizes and p-values.

Practical Implications

If the A allele of rs7834555 is confirmed as reducing beta-carotene conversion efficiency or retinol status, the practical implications follow the same logic as the better-characterized BCO1 coding variants. People who rely heavily on plant-based provitamin A sources — vegans, vegetarians, and those with limited access to animal-source foods — are most affected. Since this variant acts independently of the coding variants at rs7501331 and rs12934922, individuals who carry all three risk alleles would face cumulative impairment of their beta-carotene-to-retinol conversion pathway.

The most direct way to compensate is to include preformed vitamin A99 preformed vitamin A
Retinol from animal sources (liver, egg yolks, dairy, fatty fish) or retinyl palmitate/acetate supplements — bypasses BCO1 entirely and does not require conversion in the diet, which bypasses the BCO1 enzyme entirely and provides retinol directly to the body. For those eating a mixed diet with regular animal products, even substantially reduced BCO1 activity is unlikely to produce clinical vitamin A deficiency.

Interactions

The rs7834555 signal is proposed to be independent of the two major BCO1 coding variants: rs7501331 (Ala379Val, on chromosome 16) and rs12934922 (Arg267Ser, also chromosome 16). If confirmed, individuals carrying the A allele at rs7834555 alongside T alleles at rs7501331 and/or rs12934922 would face additive impairment of their beta-carotene conversion capacity — the combined effect exceeding any single variant alone.

The upstream regulatory BCO1 SNPs (rs6564851, rs6420424, rs11645428) on chromosome 16 are separate signals that also independently influence conversion and may interact further. The full genetic architecture of interindividual variation in beta-carotene conversion thus spans both structural (amino acid) and regulatory (expression-level) effects, with rs7834555 proposed as an additional independent determinant from a distinct genomic locus.

Nutrient Interactions

vitamin A (retinol) impaired_conversion
beta-carotene altered_metabolism

Genotype Interpretations

What each possible genotype means for this variant.

GG Normal Converter Normal

Reference genotype — no additional reduction in beta-carotene conversion from this variant

The G allele at rs7834555 is the ancestral and globally predominant allele, present at approximately 67% frequency across all populations. The GG genotype represents the reference state for this GWAS-identified signal: no directional effect on circulating carotenoid or retinol levels attributable to this specific variant.

Note that your overall beta-carotene conversion efficiency is still determined by multiple other genetic variants, most importantly the BCO1 coding variants rs7501331 (Ala379Val) and rs12934922 (Arg267Ser) on chromosome 16. This result tells you only that this particular variant is not an additional source of impairment.

AG Heterozygous Carrier Intermediate

One copy of the A allele — possible modest effect on beta-carotene status

The AG genotype places you between the two homozygous states. The effect follows an additive pattern: one copy of the A allele confers a smaller perturbation of carotenoid status than two copies would. The molecular basis is not yet established — the variant is likely a tag SNP in linkage disequilibrium with a functional regulatory element.

Given the emerging nature of the evidence for this specific variant, the practical magnitude of the effect is uncertain. The most actionable information comes from combining this result with your BCO1 coding variant status to build a fuller picture of your vitamin A conversion genetics.

AA Homozygous A Carrier Poor Converter

Two copies of the A allele — potential additional reduction in beta-carotene conversion efficiency

The AA genotype represents the homozygous risk state for this GWAS-identified signal. In an additive model, two copies of the A allele confer approximately twice the effect of a single copy on circulating carotenoid levels. Because the molecular mechanism is not yet established, the precise magnitude of effect is uncertain — but the direction is consistent: the A allele is associated with altered beta-carotene and retinol status independent of the BCO1 coding variants on chromosome 16.

If you also carry T alleles at rs7501331 (Ala379Val) and/or rs12934922 (Arg267Ser), the combined impairment to your beta-carotene conversion pathway would be cumulative. For plant-based eaters, this combination argues strongly for preformed vitamin A as a dietary priority.

The clinical significance of this variant as a standalone finding is emerging — no peer-reviewed publication has yet defined the exact effect size for rs7834555 in an adequately powered cohort. The prudent approach is to address potential conversion impairment proactively while awaiting confirmatory evidence.